• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响非酒精性脂肪性肝病进展的既存和新兴因素。

Established and emerging factors affecting the progression of nonalcoholic fatty liver disease.

机构信息

Department of Gastroenterology and Hepatology, Linköping University, Linköping, Sweden; Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.

出版信息

Metabolism. 2020 Oct;111S:154183. doi: 10.1016/j.metabol.2020.154183. Epub 2020 Feb 14.

DOI:10.1016/j.metabol.2020.154183
PMID:32061907
Abstract

Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease affecting approximately 25% of the global population. Although a majority of NAFLD patients will never experience liver-related symptoms it is estimated that 5-10% will develop cirrhosis-related complications with risk of death or need for liver transplantation. NAFLD is closely associated with cardiovascular disease and components of the metabolic syndrome. However, NAFLD is not uncommon in lean individuals and may in these subjects represent a different entity with separate pathophysiological mechanisms involved implying a higher risk for development of end-stage liver disease. There is considerable fluctuation in the histopathological course of NAFLD that may partly be attributed to lifestyle factors and dietary composition. Nutrients such as fructose, monounsaturated fatty acids, and trans-fatty acids may aggravate NAFLD. Presence of type 2 diabetes mellitus seems to be the most important clinical predictor of liver-related morbidity and mortality in NAFLD. Apart from severity of the metabolic syndrome, genetic polymorphisms and environmental factors, such as moderate alcohol consumption, may explain the variation in histopathological and clinical outcome among NAFLD patients.

摘要

非酒精性脂肪性肝病(NAFLD)已成为最常见的慢性肝病,影响着约全球 25%的人口。尽管大多数 NAFLD 患者从未出现过与肝脏相关的症状,但据估计,有 5-10%的患者会发展为与肝硬化相关的并发症,从而面临死亡或需要进行肝移植的风险。NAFLD 与心血管疾病和代谢综合征的组成部分密切相关。然而,在瘦人群体中,NAFLD 也并不罕见,在这些人群中,它可能代表着一种不同的实体,涉及不同的病理生理机制,这意味着发展为终末期肝病的风险更高。NAFLD 的组织病理学病程存在相当大的波动,这可能部分归因于生活方式因素和饮食成分。果糖、单不饱和脂肪酸和反式脂肪酸等营养素可能会加重 NAFLD。2 型糖尿病的存在似乎是 NAFLD 患者肝脏相关发病率和死亡率的最重要临床预测因素。除了代谢综合征的严重程度、遗传多态性和环境因素(如适量饮酒)外,这些因素可能解释了 NAFLD 患者在组织病理学和临床结局方面的差异。

相似文献

1
Established and emerging factors affecting the progression of nonalcoholic fatty liver disease.影响非酒精性脂肪性肝病进展的既存和新兴因素。
Metabolism. 2020 Oct;111S:154183. doi: 10.1016/j.metabol.2020.154183. Epub 2020 Feb 14.
2
Modifiers of Liver-Related Manifestation in the Course of NAFLD.非酒精性脂肪性肝病病程中与肝脏相关表现的修饰因子。
Curr Pharm Des. 2020;26(10):1062-1078. doi: 10.2174/1381612826666200310142803.
3
Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).非酒精性脂肪性肝病(NAFLD)和酒精性相关脂肪性肝病(AFLD)患者的死亡原因。
Curr Pharm Des. 2020;26(10):1079-1092. doi: 10.2174/1381612826666200128094231.
4
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
5
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学:对肝移植的影响。
Transplantation. 2019 Jan;103(1):22-27. doi: 10.1097/TP.0000000000002484.
6
The Natural Course of Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病的自然病程。
Int J Mol Sci. 2016 May 20;17(5):774. doi: 10.3390/ijms17050774.
7
Risk factors in nonalcoholic fatty liver disease.非酒精性脂肪性肝病的危险因素。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S79-S85. doi: 10.3350/cmh.2022.0398. Epub 2022 Dec 14.
8
Natural History of Nonalcoholic Fatty Liver Disease: Implications for Clinical Practice and an Individualized Approach.非酒精性脂肪性肝病自然史:对临床实践和个体化方法的启示。
Can J Gastroenterol Hepatol. 2020 Jan 21;2020:9181368. doi: 10.1155/2020/9181368. eCollection 2020.
9
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.非酒精性脂肪性肝病、代谢风险因素与肝细胞癌:一个悬而未决的问题。
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
10
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.

引用本文的文献

1
extracellular vesicles enhance gut and liver function in MAFLD.细胞外囊泡可增强非酒精性脂肪性肝病中的肠道和肝脏功能。
Front Immunol. 2025 Aug 28;16:1660131. doi: 10.3389/fimmu.2025.1660131. eCollection 2025.
2
Dysregulation and gene polymorphisms of Vitamin D receptor: its implications in lipid metabolic disorders.维生素D受体的失调与基因多态性:其在脂质代谢紊乱中的意义。
Mol Biol Rep. 2025 Jun 23;52(1):630. doi: 10.1007/s11033-025-10725-7.
3
Risk factor analysis and predictive model construction of lean MAFLD: a cross-sectional study of a health check-up population in China.
非酒精性脂肪性肝病(MAFLD)消瘦型的危险因素分析及预测模型构建:一项针对中国健康体检人群的横断面研究
Eur J Med Res. 2025 Feb 25;30(1):137. doi: 10.1186/s40001-025-02373-1.
4
MAFLD but not MASLD increases risk of all-cause mortality in regional Australia, with components of metabolic syndrome exacerbating factors: 20 year longitudinal, cohort study.在澳大利亚地区,非酒精性脂肪性肝炎(MAFLD)而非代谢相关脂肪性肝病(MASLD)会增加全因死亡风险,代谢综合征各组分起加剧作用:一项20年纵向队列研究。
Hepatol Int. 2025 Apr;19(2):384-394. doi: 10.1007/s12072-024-10748-5. Epub 2024 Dec 14.
5
Circulating lipoprotein(a) in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.非酒精性脂肪性肝病患者循环脂蛋白(a):一项系统评价和荟萃分析。
J Gastroenterol Hepatol. 2024 Dec;39(12):2572-2581. doi: 10.1111/jgh.16768. Epub 2024 Oct 17.
6
Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease.半乳糖凝集素-3 与代谢相关脂肪性肝病肝纤维化严重程度的关系。
Protein Pept Lett. 2024;31(4):290-304. doi: 10.2174/0109298665301698240404061300.
7
Influence of Sugar-Sweetened Beverages Intake on Sarcopenic Obesity, Visceral Obesity, and Sarcopenia in Lebanese Patients with MASLD: A Case-Control Study.含糖饮料摄入量对黎巴嫩非酒精性脂肪性肝病患者肌肉减少性肥胖、内脏肥胖和肌肉减少症的影响:一项病例对照研究
Healthcare (Basel). 2024 Mar 5;12(5):591. doi: 10.3390/healthcare12050591.
8
Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study.按种族和民族划分的非酒精性脂肪肝的肝脏和死亡率结局的差异:一项纵向真实世界研究。
Clin Mol Hepatol. 2023 Oct;29(4):1002-1012. doi: 10.3350/cmh.2023.0205. Epub 2023 Sep 11.
9
Waist circumference is independently associated with liver steatosis and fibrosis in LMNA-related and unrelated Familial Partial Lipodystrophy women.腰围与LMNA相关和不相关的家族性部分脂肪营养不良女性的肝脏脂肪变性和纤维化独立相关。
Diabetol Metab Syndr. 2023 Sep 7;15(1):182. doi: 10.1186/s13098-023-01156-0.
10
Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD.不良的肌肉组成是NAFLD患者全因死亡率的一个重要风险因素。
JHEP Rep. 2022 Dec 24;5(3):100663. doi: 10.1016/j.jhepr.2022.100663. eCollection 2023 Mar.